Since the presence of an active immune system has been associated with improved clinical outcomes in OC patients31, to ascertain the function of MDM4 in an immune-competent background, we utilized allograft of the murine ovarian cancer cell line ID8 in the syngeneic murine background C57BL/632. Here, MDM4 is linked to ovarian cancer.